The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of a quantitative immunofluorescent method for analysis of nuclear and cytoplasmic p53 and p21 in circulating tumor cells (CTC) as biomarkers of response to p53-targeted therapy.
Jacky Woo
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Weiguo Wu
Employment or Leadership Position - ApoCell
Vladislava O. Melnikova
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Kenna Lynn Anderes
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell
Darren W. Davis
Employment or Leadership Position - ApoCell
Stock Ownership - ApoCell